Search results for "mass [excited state]"

showing 10 items of 5250 documents

Charged jet cross section and fragmentation in proton-proton collisions at √s = 7 TeV

2019

Published by the American Physical Society under the terms of the Creative Commons Attribution 4.0 International license. Further distribution of this work must maintain attribution to the author(s) and the published article’s title, journal citation, and DOI. We report the differential charged jet cross section and jet fragmentation distributions measured with the ALICE detector in proton-proton collisions at a center-of-mass energy √s=7  TeV. Jets with pseudorapidity |η|40  GeV/c, the pythia calculations also agree with the measured charged jet cross section. pythia6 simulations describe the fragmentation distributions to 15%. Larger discrepancies are observed for pythia8. SCOAP

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Physics and Astronomy (miscellaneous)fragmentation [jet]Astrophysics::High Energy Astrophysical Phenomenameasured [cross section]transverse momentumhiukkasfysiikka01 natural sciencesscattering [pp]Nuclear physicsALICEFragmentation (mass spectrometry)0103 physical sciencesjet fragmentation010306 general physicsNuclear ExperimentPhysicsQuantum chromodynamicsPP COLLISIONSta114010308 nuclear & particles physicsPB COLLISIONS:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]TRANSVERSE-MOMENTUMVDP::Kjerne- og elementærpartikkelfysikk: 431resolution16. Peace & justicecharged particlejet cross sectionCharged particleNATURAL SCIENCES. Physics.ddc::Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]PRIRODNE ZNANOSTI. Fizika.:Nuclear and elementary particle physics: 431 [VDP]pp: scattering ; jet: fragmentation ; cross section: measured ; transverse momentum ; charged particle ; resolution ; PYTHIA ; ALICEVDP::Nuclear and elementary particle physics: 431PseudorapidityTransverse momentumPYTHIAHigh Energy Physics::Experimentproton-proton collisionsTRANSVERSE-MOMENTUM; PP COLLISIONS; PB COLLISIONS; PARTICLEPARTICLEPhysical Review D
researchProduct

Scattering Studies with Low-Energy Kaon-Proton Femtoscopy in Proton-Proton Collisions at the LHC

2020

The study of the strength and behaviour of the antikaon-nucleon ($\mathrm{\overline{K}N}$) interaction constitutes one of the key focuses of the strangeness sector in low-energy Quantum Chromodynamics (QCD). In this letter a unique high-precision measurement of the strong interaction between kaons and protons, close and above the kinematic threshold, is presented. The femtoscopic measurements of the correlation function at low pair-frame relative momentum of (K$^+$ p $\oplus$ K$^-$ $\overline{\mathrm{p}}$) and (K$^-$ p $\oplus$ K$^+$ $\overline{\mathrm{p}}$) pairs measured in pp collisions at $\sqrt{s}$ = 5, 7 and 13 TeV are reported. A structure observed around a relative momentum of 58 Me…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Protonchiral dynamicsGeneral Physics and Astronomyhiukkasfysiikkanucl-ex01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)ALICELHC HBTCorrelation functionHBT[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]scattering [p p]correlation functionKaon-ProtonNuclear Experiment (nucl-ex)Nuclear ExperimentNuclear ExperimentQuantum chromodynamicsPhysicsLarge Hadron ColliderPhysicsstrong interactionCHIRAL DYNAMICSVDP::Kjerne- og elementærpartikkelfysikk: 431SIGMA-HYPERON PRODUCTIONddc:3. Good healthPRIRODNE ZNANOSTI. Fizika.p interactions:Nuclear and elementary particle physics: 431 [VDP]CERN LHC CollNUCLEON INTERACTIONSVDP::Nuclear and elementary particle physics: 431P INTERACTIONSIsospinLHC5000 GeV-cms/nucleon 7000 GeV-cms/nucleon 13000 GeV-cms/nucleonpp collisionsParticle Physics - Experimentp p: scatteringStrong interactionLAMBDA(1405)Kaon-Proton Femtoscopy pp collisions LHCFOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Physics and Astronomy(all)Strangenesslambda(1405)114 Physical sciencesALICE; femtoscopyp-pNuclear physicsMomentumALICE LHC High-Energy Physicschiral [model]strangenessnucleon interactionsKaon-Proton ; Femtoscopy ; p-pfemtoscopyquantum chromodynamics0103 physical sciencesNuclear Physics - Experimentddc:530010306 general physicsNuclear Physicsanti-K nucleon: interactionhep-exHigh Energy Physics::PhenomenologySIGMA-HYPERON PRODUCTION; NUCLEON INTERACTIONS; CHIRAL DYNAMICS; P INTERACTIONS; LAMBDA(1405)interaction [anti-K nucleon]mass differenceNATURAL SCIENCES. Physics.Kaon-Proton Femtoscopysigma-hyperon productionHigh Energy Physics::Experimentmodel: chiralexperimental results
researchProduct

La narrativa indigenista de Amauta

2000

:LINGÜÍSTICA [UNESCO]Literature Latin AmericanUNESCO::LINGÜÍSTICAMass Communications
researchProduct

Telling it all : a genre-based approach to the analysis of the american Tabloid Talkshow

1998

:LINGÜÍSTICA [UNESCO]UNESCO::LINGÜÍSTICAMass Communications
researchProduct

Los titulares de la locura : análisis diferencial de la prensa escrita sobre la representación social de la enfermedad mental

2002

:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍAMass Communications
researchProduct

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo

2021

Multidrug resistance (MDR) mediated by ATP binding cassette subfamily B member 1 (ABCB1) is significantly hindering effective cancer chemotherapy. However, currently, no ABCB1-inhibitory drugs have been approved to treat MDR cancer clinically, mainly due to the inhibitor specificity, toxicity, and drug interactions. Here, we reported that three polyoxypregnanes (POPs) as the most abundant constituents of Marsdenia tenacissima (M. tenacissima) were novel ABCB1-modulatory pro-drugs, which underwent intestinal microbiota-mediated biotransformation in vivo to generate active metabolites. The metabolites at non-toxic concentrations restored chemosensitivity in ABCB1-overexpressing cancer cells v…

ABCC1 ATP binding cassette subfamily C member 1IC50 half maximal inhibitory concentrationMultidrug resistancePharmacologyNADPH reduced nicotinamide adenine dinucleotide phosphateF bioavailabilitychemistry.chemical_compoundPCR polymerase chain reaction0302 clinical medicineMDR multidrug resistanceECL electrochemiluminescencet1/2 elimination half-lifeLC–MS liquid chromatography coupled with mass spectrometryN.D. not detectedGeneral Pharmacology Toxicology and PharmaceuticsBBB blood–brain barriermedia_commonATF3 activating transcription factor 30303 health sciencesChemistryABC ATP-binding cassetteNMPA National Medical Products AdministrationPXR pregnane X receptorSDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresisHBSS Hankʹs balanced salt solutionABCB1Combination chemotherapyProdrugMarsdenia tenacissimaCmax peak concentrationPaclitaxelGAPDH glyceraldehyde-3-phosphate dehydrogenase030220 oncology & carcinogenesisBHI brain heart infusionOriginal ArticleAUC0–∞ area under plasma concentration vs. time curveMRT mean residence timeDrugmedia_common.quotation_subjectRM1-950Vd volume of distributionABCB1 ATP binding cassette subfamily B member 1UIC-2 mouse monoclonal ABCB1 antibodyABCG2 ATP binding cassette subfamily G member 2Combination chemotherapyCYP cytochrome P450 isozymePI propidium iodideTEER transepithelial electrical resistance03 medical and health sciencesPBS phosphate buffer salineFBS fetal bovine serumDox doxorubicinIn vivoPOP polyoxypregnanemedicine030304 developmental biologyEVOM epithelial tissue voltohmmeterTmax time for peak concentrationCancerLBE lowest binding energyPE phycoerythrinmedicine.diseaseMultiple drug resistancePolyoxypregnanePapp apparent permeabilityN.A. not applicableCancer cellH&E hematoxylin and eosinMDR1a multidrug resistance protein 1aTherapeutics. PharmacologyqPCR quantitative PCRM. tenacissima Marsdenia tenacissimaCL clearanceSD standard derivationActa Pharmaceutica Sinica B
researchProduct

Considering syntrophic acetate oxidation and ionic strength improves the performance of models for food waste anaerobic digestion.

2021

Current mechanistic anaerobic digestion (AD) models cannot accurately represent the underlying processes occurring during food waste (FW) AD. This work presents an update of the Anaerobic Digestion Model no. 1 (ADM1) to provide accurate estimations of free ammonia concentrations and related inhibition thresholds, and model syntrophic acetate oxidation as acetate-consuming pathway. A modified Davies equation predicted NH3 concentrations and pH more accurately, and better estimated associated inhibitory limits. Sensitivity analysis results showed the importance of accurate disintegration kinetics and volumetric mass transfer coefficients, as well as volatile fatty acids (VFAs) and hydrogen up…

ADM1Environmental EngineeringHydrogenchemistry.chemical_elementBioengineeringAcetatesModellingAmmoniachemistry.chemical_compoundBioreactorsMass transferAnaerobic digestionAnaerobiosisWaste Management and DisposalDavies equationchemistry.chemical_classificationAmmonia inhibitionRenewable Energy Sustainability and the EnvironmentOsmolar ConcentrationSyntrophic acetate oxidationGeneral MedicineRefuse DisposalAnaerobic digestionFood wastechemistryIonic strengthFoodEnvironmental chemistryPropionateMethaneBioresource technology
researchProduct

Stable isotopes covering 96-7 ka BP from stalagmite CM (Santo Tomas Cave, Cuba)

2020

We present a new speleothem trace element and stable isotope record, which extends previous paleoclimate evidence from Cuban speleothems to the last 96 ka. Stable isotope samples were micromilled at a resolution of 0.10-0.33mm, and measured using an IRMS equipped with a Gasbench. Line scans of Element/Calcium ratios of the speleothem were measured by laser ablation ICPMS and were reduced to the resolution of the stable isotope records.

AGESpeleothem sampleδ13C stackedδ13CEarth System Researchpaleoclimatologyδ18O stackedstackedCentral Americaδ18OMass spectrometer DeltaPlusXL coupled to a Gasbench IIspeleothemStable isotopes
researchProduct

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.

2022

Funder: European Commission

ALTtype 2 diabetes mellitusROC receiving operator characteristicaspartate aminotransferaseHSDLDL low-density lipoproteinUHPLC ultrahigh-performance liquid chromatographyROCHCCNon-alcoholic steatohepatitisGCPCANASHGastroenterology2-HB 2-hydroxybutanoic acid; 3-HB 3-hydroxybutanoic acid; ALT alanine aminotransferase; AST aspartate aminotransferase; CE cholesterol ester; Cer ceramide; FFA free fatty acid; FLIP Fatty Liver Inhibition of Progression; Fibrosis; GC gas chromatography; HCC hepatocellular carcinoma; HSD honest significant difference; LC lipid cluster; LDL low-density lipoprotein; LM lipid and metabolite; LMC lipid metabolite and clinical variable; LPC lysophosphatidylcholine; Lipidomics; Mass spectrometry; Metabolomics; NAFL non-alcoholic fatty liver; NAFLD non-alcoholic fatty liver disease; NAS NASH activity score; NASH non-alcoholic steatohepatitis; NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network; NRR non-rejection rate; Non-alcoholic steatohepatitis; PC(O) ether PC; PC phosphatidylcholine; PCA principal component analysis; PE phosphatidylethanolamine; QTOFMS quadrupole-time-of-flight mass spectrometry; ROC receiving operator characteristic; SAF steatosis activity and fibrosis; SM sphingomyelin; T2DM type 2 diabetes mellitus; TG triacylglycerol; UHPLC ultrahigh-performance liquid chromatographySAFSAF steatosis activity and fibrosisLM lipid and metabolitehonest significant differenceHSD honest significant differenceTG triacylglycerolnon-rejection ratecholesterol esterPCPEGC gas chromatographyfree fatty acidFLIPNASH non-alcoholic steatohepatitisNIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkBIOMARKERST2DMPE phosphatidylethanolamineLDLlipidNAFLDFFA free fatty acid2-HBMetabolomicsNAFL non-alcoholic fatty liverLMCphosphatidylcholineScience & TechnologySM sphingomyelinGastroenterology & HepatologyMass spectrometryactivitynutritional and metabolic diseasesT2DM type 2 diabetes mellitusACIDSreceiving operator characteristicdigestive system diseasesquadrupole-time-of-flight mass spectrometryLC lipid clusterlow-density lipoproteinNAS2-HB 2-hydroxybutanoic acidNAS NASH activity scoreQTOFMSether PCNRRSCORING SYSTEMprincipal component analysisgas chromatographyLC2-hydroxybutanoic acidPROGRESSIONAST aspartate aminotransferaseLMPC phosphatidylcholinePC(O)MARKERSUHPLCsteatosisTOOLImmunology and AllergyINSULIN-RESISTANCECerSMFatty Liver Inhibition of Progressionhepatocellular carcinoma2-HB 2-hydroxybutanoic acid NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network NRR non-rejection rate Non-alcoholic steatohepatitis PC(O) ether PC PC phosphatidylcholine PCA principal component analysis PE phosphatidylethanolamine QTOFMS quadrupole-time-of-flight mass spectrometry ROC receiving operator characteristic SAF steatosis activity and fibrosis SM T2DM type 2 diabetes mellitus TG triacylglycerol UHPLC ultrahigh-performance liquid chromatographyultrahigh-performance liquid chromatographyCELPC3-HBNAFLnon-alcoholic fatty liverTGtriacylglycerolNRR non-rejection rateLife Sciences & BiomedicineNAFLD non-alcoholic fatty liver diseaseFLIP Fatty Liver Inhibition of Progressionalanine aminotransferasemetaboliteCer ceramideCE cholesterol estersphingomyelinlysophosphatidylcholineand fibrosisALT alanine aminotransferaseInternal MedicineceramideNational Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkAST3-HB 3-hydroxybutanoic acidQTOFMS quadrupole-time-of-flight mass spectrometryPCA principal component analysisLPC lysophosphatidylcholineHepatologynon-alcoholic fatty liver diseaseand clinical variablePC(O) ether PC3-hydroxybutanoic acidFibrosisNASH activity scoreNIDDK NASH-CRNlipid clusterlipid and metabolitephosphatidylethanolamineLipidomicsLMC lipid metabolite and clinical variableFFAHCC hepatocellular carcinomaJHEP reports : innovation in hepatology
researchProduct

An alternative conception of PM10 concentration changes after short-term precipitation in urban environment

2018

Abstract In the article, a linear model is presented which describes a reduction of PM10 mass concentration in relation to the type of precipitation and water vapour content in the air. The model was built using covariance analysis. In studies of PM10 concentration changes, the results of 247 observations were used, which were carried out in the urban area. Concentration changes were archived during short-term (30 min) convection and large-scale rainfalls. For the determination of PM10 mass concentration, the reference method was used. To describe changes in PM10 concentration in the air after precipitation, a series of linear models were created, in which the explanatory variables were: th…

ANCOVAFluid Flow and Transfer ProcessesAtmospheric ScienceEnvironmental EngineeringCoefficient of determination010504 meteorology & atmospheric sciencesTroposphereRainLinear modelMechanical EngineeringLinear modelHumidity010501 environmental sciencesParticulatesAtmospheric sciences01 natural sciencesPollutionSnowHomoscedasticityEnvironmental scienceMass concentration (chemistry)PrecipitationAerosolWater vapor0105 earth and related environmental sciencesJournal of Aerosol Science
researchProduct